Keyword: Pricing

Logistics & Supply Chain

Substance-based Supply-Chain Planning under BEPS

28.07.2015 - The agility of supply chains of multinationals driven by the globalization and continuous business changes combined with favorable tax regimes in various jurisdictions has given a...

News

European Price Wars Seen Shaping up Over Hepatitis C Drugs

20.01.2015 - Europe, where about 15 million people are believed to be infected with hepatitis C, could become the next battleground between US drugmakers Gilead Sciences and AbbVie in their...

News

Express Scripts to Reimburse AbbVie Hepatitis C Drug

23.12.2014 - The largest pharmacy benefit manager in the US, Express Scripts, has negotiated a cheaper price from AbbVie for its Viekira Pak hepatitis C treatment approved by the US Food and...

Markets & Companies

China’s rising salaries improve Europe’s competitiveness

08.05.2014 - Variety of Factors Influence Salaries - In the last 10 years, salaries in China have been rising at an average annual rate of about 14%. Though this rate has recently been somewhat...

News

Sinopec to Cut Spending After Earnings Drop

24.03.2014 - After reporting a 35% earnings decline for the 2013 fourth quarter, Chinese oil and petrochemicals giant Sinopec said it would cut capital spending to just under $26.2 billion in...

News

Countering Commoditization

04.03.2014 - From Unique To Common - In the business world, commoditization is defined as the process by which goods that are initially distinguishable in terms of attributes (uniqueness or...

Plant Construction & Process Technology

Rethinking Biosimilar Development

08.11.2013 - The World's Biologics Drug Price Problem - Drug expenses have become a significant item in household and government budgets around the world as more innovative and pricey biotech...

News

Drugmakers Face More Scrutiny of Discordant U.S. Prices

11.05.2013 - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer and...